Respiratory devices with potential being modified to ventilators by company 2020

Number of respiratory devices with potential to be modified for ventilators by Emergency Use Authorizations (EUAs) as of end-March 2020, by company*

Company nameNumber of approvals eligible for EUAs
Resmed 24
Philips 12
Fisher & Paykel Healthcare 8
Getinge 6
General Electric 6
Hill-Rom 5
Hamilton Company 5
Mindray Medical International 4
3B Medical 4
Vyaire Medical 3
Drägerwerk 3
Medtronic 3
Thornhill Medical 3
Created with Highcharts 7.2.2Company nameNumber of approvals eligible for EUAs2424121288666655554444333333333333ResmedPhilipsFisher & Paykel HealthcareGetingeGeneral ElectricHill-RomHamilton CompanyMindray Medical International3B MedicalVyaire MedicalDrägerwerkMedtronicThornhill MedicalApex MedicalDrive Devilbiss Healthcare
0246810121416182022242628
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2020

Region

United States

Survey time period

2014 to 31 March 2020

Supplementary notes

* Approvals from 2014 until the given date.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Statistics on " Coronavirus: the pharma and medtech response "

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

18
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.